Sebela Pharmaceuticals Inc. is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women’s health diseases. To fulfill our commitment to improving patient’s lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities.
Sebela operates from two locations with an office in Roswell, Georgia, and headquarters in Dublin, Ireland.
Sebela operates from two locations with an office in Roswell, Georgia, and headquarters in Dublin, Ireland.
Location: United States, Georgia, Roswell
Employees: 201-500
Founded date: 2013
Investors 3
| Date | Name | Website |
| 06.10.2021 | Mubadala C... | mubadala.c... |
| - | Avego | avego.com |
| - | DFW Capita... | dfwcapital... |
Mentions in press and media 5
| Date | Title | Description |
| 30.10.2025 | Phase 3 Data Publication in Contraception | ROSWELL, GA, October 27, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the journal Contraception has awarded the publication of Phase 3 data of MIUDELLA® (copper intrauterine system) one of the Da... |
| 23.03.2021 | CellMax Life and Sebela Pharmaceuticals Enter Strategic Development and Commercialization Partnership for FirstSight™ Blood Test for Detection of Colorectal Cancer and Pre-Cancer | SUNNYVALE, Calif. and ROSWELL, Ga., March 23, 2021 /PRNewswire/ -- CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela Pharmaceuticals, a market leader in gas... |
| 20.01.2015 | DFW Capital Partners promotes DeVer Warner to Principal | DFW Capital Partners announced today that DeVer F. Warner has been promoted to the position of Principal. Based in the firm’s Teaneck, NJ office, DeVer joined DFW in 2011 as an Associate. DeVer has been actively involved in sourcing and exe... |
| 23.12.2013 | DFW Closes Fund IV at $162.5 Million, Exceeding Target | DFW Capital Partners announced today that it has held a final closing on DFW Capital Partners IV, L.P., an investment partnership dedicated to making control investments in lower-middle market service companies. DFW IV is capitalized with $... |
| 06.09.2013 | DFW Capital Partners leads equity investment in Sebela Pharmaceuticals | DFW Capital Partners announced today that on August 26, 2013 it completed an equity investment in the parent entity of Sebela International, Ltd and Sebela Pharmaceuticals, Inc. (“Sebela”), a newly-formed specialty pharmaceutical acquisitio... |